bromo benzyl glutathione cyclopentyl diester SID 341549469 MR1 LIGANDS AND PHARMACEUTICAL COMPOSITIONS
MR1 LIGANDS AND PHARMACEUTICAL COMPOSITIONS FOR IMMUNOMODULATION Dimensions Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes Oncotarget Inhibition of GLO1 in Glioblastoma Multiforme Increases DNA AGEs, Stimulates RAGE Expression, and Inhibits Brain Tumor Growth in Orthotopic Mouse Models S p bromobenzyl glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti tumor effect in soft tissue sarcoma preclinical models Oncogene Glutathione Derivative an overview ScienceDirect Topics Metabolic drivers of genome instability in cancer: mechanisms and therapeutic opportunities Experimental Hematology & Oncology Springer Nature Link
Pay in 4 interest-free payments of $6.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15




